CDKN2A and cancer: These observations support the notion that deregulated E2F activation via the ERE73s elements significantly contributes to the enhanced cancer cell specificity observed in ERE73 (1 + 2)-ARF (−13) and ERE73 (3 + 4)-ARF (−13) constructs.